Lockdowns are dragging on across Europe, and for some people who ve had COVID-19, the symptoms of the disease can also linger for months.
While disease in children does tend to be milder, there is emerging evidence that they’re not exempt from so-called Long COVID .
The World Health Organization, which has called for more research on the topic, estimates that around one in 10 people who have contracted the disease are still unwell 12 weeks after testing positive.
Data collected in the UK between April and December 2020 suggests that children are also affected. The Office for National Statistics estimates that 12.9 percent of respondents aged between 2 and 11, and 14.5 percent of those between 12-16 reported symptoms of fatigue, cough, headache, loss of taste or smell or muscle aches five weeks after infection.
Germany
United-kingdom
Badalona
Comunidad-autonoma-de-cataluna
Spain
Germans
Institut-guttmann
Triasi-pujol
Georgina-calero
World-health-organization
Office-for-national-statistics
National-statistics
Credit: Dana-Farber Cancer Institute
In a major advance in the treatment of multiple myeloma, a CAR T-cell therapy has generated deep, sustained remissions in patients who had relapsed from several previous therapies, an international clinical trial has found.
In a study posted online today by the
New England Journal of Medicine, trial leaders report that almost 75% of the participants responded to the therapy, known as idecabtagene vicleucel (ide-cel), and one-third of them had a complete response, or disappearance of all signs of their cancer. These rates, and the duration of the responses, are significantly better than those produced by currently available therapies for patients with multiple relapses, according to investigators.
New-york
United-states
Eppendorf
Nordrhein-westfalen
Germany
Hamburg
Milan
Lombardia
Italy
California
Leuven
Region-flamande